Back
Nektar Therapeutics Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
33
NKTR
Nektar Therapeutics
Last Price:
$51.10
Seasonality Move:
11.58%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiNektar Therapeutics Stock Forecast
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 27.8% based on the past 31 years of stock performance.
-
Nektar Therapeutics has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
-
Is Nektar Therapeutics Stock Undervalued?The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Nektar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 27.8% based on the past 31 years of stock performance.
Nektar Therapeutics Stock Rating
Sell
33
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics overpriced?
-
Nektar Therapeutics has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
Nektar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com
52-Week Data
52-Week High:
66.92
52-Week Low:
6.48
Prediction Charts
Market Cap:
884.4M
Price in USD:
51.12
Volume:
914.3K
Beta:
1.25
Technical Analysis
SMA50:
58.52
SMA100:
47.36
SMA200:
30.43
52-Wk Change:
234.12%
Stock Predictions
-
Is Nektar Therapeutics stock public?Yes, Nektar Therapeutics is a publicly traded company.
-
What is the Nektar Therapeutics stock quote today?The Nektar Therapeutics stock price is 51.12 USD today.
-
How to buy Nektar Therapeutics stock online?You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-21 | 55.30 | 54.28 | 56.50 | 53.29 |
| Nov-24 | 55.08 | 58.64 | 59.29 | 55.08 |
| Nov-25 | 58.64 | 60.35 | 61.00 | 58.01 |
| Nov-26 | 63.10 | 65.69 | 66.60 | 60.35 |
| Nov-28 | 66.41 | 65.21 | 66.86 | 64.25 |
| Dec-1 | 64.01 | 61.11 | 64.31 | 59.95 |
| Dec-2 | 61.11 | 54.85 | 61.40 | 54.65 |
| Dec-3 | 55.00 | 57.13 | 57.37 | 53.55 |
| Dec-4 | 56.90 | 57.69 | 57.86 | 54.75 |
| Dec-5 | 57.99 | 56.90 | 58.10 | 55.67 |
| Dec-8 | 57.83 | 57.28 | 58.94 | 56.54 |
| Dec-9 | 57.08 | 58.78 | 59.23 | 56.01 |
| Dec-10 | 58.17 | 57.74 | 58.99 | 56.70 |
| Dec-11 | 57.33 | 51.12 | 57.90 | 51.04 |
Nektar Therapeutics Earnings
Nektar Therapeutics Earnings Report: Per Share Nektar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Nektar Therapeutics Forecast Revenue Growth
Nektar Therapeutics Stock Analysis: Historical quarterly revenues per share for Nektar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.